Search Within

Daniel Hirschhorn Cymerman

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (11)
  2. GSK Faculty (11)
  3. Human Oncology and Pathogenesis Program (11)
  4. Melanoma and Immunotherapeutics Service (11)
  5. Sloan Kettering Institute Postdocs (11)
  6. Solid Tumor Oncology Division (11)

More Groups

People
  1. Jedd Wolchok (11)
  2. Taha Merghoub (11)
  3. Alan Houghton (8)
  4. Gabrielle Rizzuto (7)
  5. Adam Cohen (4)
  6. Alexander Lesokhin (4)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2019 (1)
  5. 2011 (1)
  6. 2010 (2)

More Years

Publications
  1. Journal of Experimental Medicine (3)
  2. Blood (2)
  3. Immunity (1)
  4. JCI Insight (1)
  5. Journal of Clinical Investigation (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. Rockefeller University Press (3)
  2. American Society of Hematology (2)
  3. Amer Soc Clinical Investigation Inc (1)
  4. American Society for Clinical Investigation (1)
  5. American Society of Clinical Oncology (1)
  6. Cell Press (1)

More Publishers

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions
    Journal Article

    Schad, S. E.; Chow, A.; Mangarin, L.; Pan, H.; Zhang, J.; Ceglia, N.; Caushi, J. X.; Malandro, N.; Zappasodi, R.; Gigoux, M.; more...
    Journal of Experimental Medicine (2022)

    Fulltext@MSK | Save
  • Cyclophosphamide enhances the antitumor potency of GITR engagement by increasing oligoclonal cytotoxic T cell fitness
    Journal Article

    Hirschhorn, D.; Betof Warner, A.; Maniyar, R.; Chow, A.; Mangarin, L. M. B.; Cohen, A. D.; Hamadene, L.; Rizzuto, G. A.; Budhu, S.; Suek, N.; more...
    JCI Insight (2021)

    Fulltext@MSK | Save
  • In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors
    Journal Article

    Khalil, D. N.; Suek, N.; Campesato, L. F.; Budhu, S.; Redmond, D.; Samstein, R. M.; Krishna, C.; Panageas, K. S.; Capanu, M.; Houghton, S.; more...
    Journal of Clinical Investigation (2019)

    Fulltext@MSK | Save
  • Monocytic CCR2+myeloid derived suppressor cells promote immune escape by limiting activated CD8 T cell infiltration into the tumor microenvironment
    Meeting Abstract

    Lesokhin, A.; Hohl, T.; Merghoub, T.; Hirschhorn-Cymerman, D.; Pamer, E. G.; Houghton, A. N.; Wolchok, J. D.
    Blood (2011)

    Fulltext@MSK | Save
  • Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs
    Journal Article

    Nakahara, T.; Uchi, H.; Lesokhin, A. M.; Avogadri, F.; Rizzuto, G. A.; Hirschhorn-Cymerman, D.; Panageas, K. S.; Merghoub, T.; Wolchok, J. D.; Houghton, A. N.
    Blood (2010)

    Fulltext@MSK | Save
  • Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation
    Journal Article

    Cohen, A. D.; Schaer, D. A.; Liu, C.; Li, Y.; Hirschhorn-Cymmerman, D. ; Kim, S. C.; Diab, A.; Rizzuto, G.; Duan, F.; Perales, M. A.; more...
    PLoS ONE (2010)

    Fulltext@MSK | Save
  • Self-antigen-specifc CD8(+) T cell precursor frequency determines the quality of the antitumor immune response
    Journal Article

    Rizzuto, G. A.; Merghoub, T.; Hirschhorn-Cymerman, D.; Liu, C.; Lesokhin, A. M.; Sahawneh, D.; Zhong, H.; Panageas, K. S.; Perales, M. A.; Altan-Bonnet, G.; more...
    Journal of Experimental Medicine (2009)

    Fulltext@MSK | Save
  • OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis
    Journal Article

    Hirschhorn-Cymerman, D.; Rizzuto, G. A.; Merghoub, T.; Cohen, A. D.; Avogadri, F.; Lesokhin, A. M.; Weinberg, A. D.; Wolchok, J. D.; Houghton, A. N.
    Journal of Experimental Medicine (2009)

    Fulltext@MSK | Save
  • Mechanisms of immunization against cancer using chimeric antigens
    Journal Article

    Engelhorn, M. E.; Guevara-Patiño, J. A.; Merghoub, T.; Liu, C.; Ferrone, C. R.; Rizzuto, G. A.; Cymerman, D. H.; Posnett, D. N.; Houghton, A. N.; Wolchok, J. D.
    Molecular Therapy (2008)

    Fulltext@MSK | Save